Search
Selected Filter
Filter Results
Displaying 281–290 of 306 research results for “retinitis pigmentosa”
-
May 19, 2022
ProQR’s Sepofarsen Improves Vision Significantly for Girl with LCA10
However, the Phase 2/3 Illuminate trial for sepofarsen didn’t meet its endpoints at 12 months
-
May 13, 2022
Enhanced Implantable Miniature Telescope Moving into Clinical Trial for AMD Patients
The device is designed for people with late-stage AMD who have no treatment options
-
Mar 7, 2022
Neurogene to Launch Gene Therapy Clinical Trial for Children with Batten Disease
The treatment will be delivered to the vitreous of the eye and ventricles of the brain
-
Feb 1, 2022
Genentech-Roche Receives FDA Approval for Vabysmo for Treatment of Wet AMD and DME
This new treatment can reduce the frequency of injections into the eye
-
Jan 28, 2022
Kriya Therapeutics Licenses Emerging Foundation-Funded Dry AMD Gene Therapy
The Foundation Fighting Blindness is funding Bärb Rohrer, PhD, Medical University of South Carolina, to evaluate safety and efficacy of the gene therapy in a large animal model
-
Oct 25, 2021
FDA Approves Genentech’s Susvimo for Treating Wet AMD
The approach significantly reduces the need for regular ocular injections.
-
Sep 10, 2021
Apellis to Seek FDA Approval of its Dry AMD Drug
Known as APL-2, the drug met its primary endpoint in the OAKS clinical trial but not the DERBY trial
-
Jun 15, 2021
Biogen’s Phase 3 Clinical Trial for its Choroideremia Gene Therapy Doesn’t Meet Endpoints
Additional results from the trial will be reported at a future scientific meeting
-
Mar 16, 2021
Foundation’s No-Cost Program Increased Genetic Testing Rates for IRD Patients
More than 8,000 people have applied for genetic testing through the Foundation’s program
-
Feb 11, 2021
Are You on the Clinical Trial Radar Screen?
Therapy developers use the My Retina Tracker Registry to recruit for human studies of emerging therapies